Clinical Trial Update: Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care As Usual Only [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial is evaluating remote symptoms monitoring using Resilience PRO versus care as usual in cancer patients; the study is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Resilience | Conditions: Cancer | Phase 3 | Status: RECRUITING